Data Insights And AI Are Maximizing The Value Of Medtronic’s ICM Family

With AI Performed In The Cloud, R&D Has Been Truly Freed Up

The UK’s NICE recommended Medtronic’s implantable cardiac monitor, Reveal LINQ, as a cost-effective use of NHS resources with certain parameters to detect atrial fibrillation after cryptogenic stroke. LINQ II has seen the technology enhanced with the input of AccuRhythm AI algorithms.

Anatomy of Human Heart

Medtronic plc’s integration of artificial intelligence (AI) into its implantable cardiac monitor (ICM) R&D program has been transformative, says Felicia Longobardi, the company’s cardiovascular diagnostics and services business unit director for western Europe.

Some 1.4 million Europeans experience ischemic strokes annually, and a quarter of them remain cryptogenic even after a comprehensive diagnostic...

More from Innovation

Podcast: ADDF’s Karen Harris On Investing In Alzheimer’s Like A VC

 
• By 

A discussion with Karen Harris, CFO of the Alzheimer's Drug Discovery Foundation, about the foundation's investment strategy, biotech and investor sentiment at the recent BIO conference and what innovations give her hope for Alzheimer's patients.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

 
• By 

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.

MitoRx’s Muscle-Preserving Obesity Drug Takes Aim At GLP-1 Limitations

 
• By 

UK biotech targets the root cause of metabolic disease while preserving muscle mass in a crowded obesity market.

BioBytes: Qubit Pharmaceuticals Unveils Quantum AI Model For Drug Discovery

 
• By 

Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.

More from In Vivo